UC Berkeley Fends off DTC Genomics Critics; Other Schools Mull Genetic Tests as Educational Tools
By Turna Ray,
GenomeWeb
| 05. 25. 2010
[Quotes CGS]
[updated May 26]
Going ahead with its plans to offer voluntary genetic testing to incoming freshman, the University of California, Berkeley, seems to not be deterred by numerous detractors of the direct-to-consumer genomics model who have criticized the effort.
UC Berkeley last week announced its plan to launch a voluntary program this fall that will test students in the Class of 2014 for three genes involved in the metabolization of alcohol, lactose, and folates. The announcement capped several controversial weeks for the DTC genomics sector, during which the marketing practices of Pathway Genomics brought regulatory action from the US Food and Drug Administration and spurred a congressional probe into the consumer genomics industry (PGx Reporter 05/19/10).
Upon announcing its gene testing plans as part of its "On the Same Page" program intended to introduce incoming students to an intellectual or thought-provoking experience, at least two organizations, the Center for Genetics and Society and the Council for Responsible Genetics, urged UC Berkeley to halt its plans.
In a statement on the CGS website, an analyst from the center pointed...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...